Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02657889 |
|---|---|
| Brief Title: | Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer (TOPACIO) |
| First Submitted : | January 8, 2016 |
| First Submitted that Met QC Criteria : | January 13, 2016 |
| First Posted : | January 18, 2016 (Estimate) |
| Results First Submitted : | December 17, 2019 |
| Results First Submitted that Met QC Criteria : | February 4, 2020 |
| Results First Posted : | February 11, 2020 |
| Last Update Submitted that Met QC Criteria : | December 17, 2020 |
| Last Update Posted : | January 13, 2021 |